Influx Healthtech IPO
GMP, Subscription, Price, Dates & Financial Details
Influx Healthtech, headquartered in Mumbai, is a prominent player in the healthcare sector, specializing in contract manufacturing and third-party production. The company operates three state-of-the-art manufacturing facilities in Thane, Maharashtra, spanning approximately 6,500 sq. ft., 13,000 sq.…
Open Date
Wed, 18 Jun 2025
Close Date
Fri, 20 Jun 2025
Price Band
₹ 91 – 96
Lot Size
1200
Issue Size
₹ 58.57 Cr
Minimum Investment
₹ 230,400 (2400 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Influx Healthtech IPO has successfully completed its IPO process and is now listed on NSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹58.57 Crore, comprising a fresh issue of 50.00 Lakh equity shares aggregating to ₹48.00 Crore and an offer for sale (OFS) of 11.00 Lakh equity shares aggregating to ₹10.56 Crore by the existing shareholders.
The Influx Healthtech IPO remained open for subscription from June 18, 2025, to June 20, 2025. The basis of allotment was finalized on June 23, 2025, and the company's shares were listed on NSE SME Platform on June 25, 2025.
The company had fixed the price band at ₹91 to ₹96 per share, with a lot size of 1200 shares. Retail investors were required to make a minimum investment of ₹230,400 (based on the upper price band) to apply for one lot.
Maashitla Securities Pvt. Limited served as the registrar to the issue. Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Influx Healthtech Limited is now a publicly listed company on NSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Influx Healthtech IPO Timeline (Tentative)
- IPO Open Date
- Wed, 18 Jun 25
- IPO Close Date
- Fri, 20 Jun 25
- Basis of Allotment
- Mon, 23 Jun 25
- Initiation of Refunds
- Tue, 24 Jun 25
- Credit of Shares to Demat
- Tue, 24 Jun 25
- Listing Date
- Wed, 25 Jun 25 — NSE & BSE
Open Date
18 June 2025
Close Date
20 June 2025
Basis Of Allotment
23 June 2025
Listing Date
25 June 2025
IPO Subscription
Check Live Subscription →The Influx Healthtech IPO has received bids for 81,75,38,400 shares against 40,58,400 shares offered, resulting in an overall subscription of 201.44x. the NII category is subscribed 481.47x, Retail Investors 117.7x, and QIBs 137.87x.
QIB
137.87x
NII
481.47x
RII
117.7x
Total
201.44x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 20,29,200 shares, representing 50% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 11,59,200 shares (28.56%), while Non-Institutional Investors (NIIs) receive 8,70,000 shares (21.44%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 1,159,200 | 28.56% |
| Non-Institutional | 870,000 | 21.44% |
| Retail Investors | 2,029,200 | 50% |
| Total | 4,058,400 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 70.3 | 41.1 | 28.3 |
| Revenue | 104.99 | 100.1 | 76.07 |
| Profit After Tax | 13.37 | 11.22 | 7.2 |
| Net Worth | 36.15 | 22.87 | 11.65 |
| Reserve & Surplus | 18 | 22.85 | 11.63 |
| Total Borrowings | 0.22 | 0.32 | 0.8 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Influx Healthtech Limited KPI Information
| Particular | KPI as of Mon, Mar 31, 2025 |
|---|---|
| ROE % | 36.98 |
| ROCE % | 49.17 |
| Debt / Equity | 0.01 |
| RoNW % | 36.98 |
| PbW | 7.62 |
| Pat Margin % | 12.75 |
Peers Comparison
No Peer Comparision Available
About Influx Healthtech Limited
Influx Healthtech, headquartered in Mumbai, is a prominent player in the healthcare sector, specializing in contract manufacturing and third-party production. The company operates three state-of-the-art manufacturing facilities in Thane, Maharashtra, spanning approximately 6,500 sq. ft., 13,000 sq. ft., and 14,000 sq. ft., respectively. Each facility is certified under GMP, HACCP, ISO 22000, and Halal standards, and is equipped with modern machinery, a dedicated quality control department, and a skilled workforce.
Influx Healthtech focuses on a diverse range of product categories, including dietary and nutritional supplements, cosmetics, ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company also manufactures active pharmaceutical ingredients (APIs) used in tablets, capsules, and injectable formulations.
Its Contract Development and Manufacturing Organization (CDMO) clientele includes well-known names such as Bling Brands, Pursuit of Wellness, Aarkios Health, HSHS Nutraceuticals, Novus Life Science, Bruder Life Science, Fredun Pharmaceuticals, and BigFlex Lifescience. In Fiscal Year 2024, the production capacities for Unit 1, Unit 2, and Unit 3 were 1,100 kg, 1,700 kg, and 7,300 kg, respectively. Influx Healthtech employs a dedicated workforce of 165 permanent staff members.
Influx Healthtech IPO Promoters
- Mr. Munir Abdul Ganee Chandniwala
- Mrs. Shirin Munir Ahmed Chandniwala
- Mr. Abdul Ganee Abdul Rasul Chandniwala
Promoters Holding
Holding Pre Issue
99.85%
Holding Post Issue
73.53%
Influx Healthtech IPO Objective
The Company Influx Healthtech IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
- Purchase of Machineries for Homecare and Cosmetic Division
- General corporate purposes
Influx Healthtech Limited Address / Contact Details
Influx Healthtech Limited
109, Ghanshyam Enclave Premises Co-op
Soc Plot No. 856, Laljipada
Kandivali West,
Mumbai, Maharashtra
Phone: +91 7045997809
Email: cs@influxhealthtech.com
Website: https://influxhealthtech.com/
IPO Snapshot
Influx Healthtech IPO Lot Size
The Influx Healthtech IPO has a lot size of 1,200 shares. Retail investors require a minimum investment of ₹1,15,200 by applying for 1 lot (1,200 shares). The maximum application allowed for the retail category is 1 lots (1,200 shares), requiring an investment of ₹1,15,200.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | 115,200.00 |
| Retail (Max) | 1 | 1,200 | 115,200.00 |
| S-HNI (Min) | 2 | 2,400 | 230,400.00 |
Issue Reservation
- QIB — 28.56%
- NII — 21.44%
- RII — 50%
Book Running Lead Managers
- Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Influx Healthtech IPO?
Influx Healthtech IPO is a Book-building IPO with a total issue size of ₹58.57 crore. The Influx Healthtech IPO price band is ₹91 to 96 per share. The Influx Healthtech IPO subscription opens on Wed, Jun 18, 2025, and closes on Fri, Jun 20, 2025. The Influx Healthtech IPO will be listed on the NSE. Maashitla Securities Pvt. Limited is the registrar for the Influx Healthtech IPO.
When will the Influx Healthtech IPO open for subscription?
The Influx Healthtech IPO opens on Wed, Jun 18, 2025 and closes on Fri, Jun 20, 2025
What is Influx Healthtech IPO Price Band?
Influx Healthtech IPO Price Band is ₹91 to 96 per share.
What is Influx Healthtech IPO Lot Size?
Influx Healthtech IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹230400 based on the upper price band
What is the minimum investment for Influx Healthtech IPO?
The minimum investment for Influx Healthtech IPO is ₹230400, based on one lot of 1200 shares at the upper price band of ₹96 per share.
How to apply for Influx Healthtech IPO?
Investors can apply for the Influx Healthtech IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jun 20, 2025. The application amount remains blocked until the Influx Healthtech IPO allotment is finalized.
What is Influx Healthtech IPO Issue Size?
Influx Healthtech IPO issue size is ₹58.57 crores.
What is the Influx Healthtech IPO Allotment Date?
Influx Healthtech IPO allotment date is Mon, Jun 23, 2025.
Who is the Influx Healthtech IPO Registrar?
The registrar for Influx Healthtech IPO is Maashitla Securities Pvt. Limited. Investors can go to Maashitla Securities Pvt. Limited website to check Influx Healthtech IPO allotment status, refund processing, and other IPO-related information.
What is the Influx Healthtech IPO GMP?
The Influx Healthtech IPO GMP (Grey Market Premium) is ₹20 as of Wed, Jun 25, 2025. Based on the upper price band of ₹96 per share, the estimated Influx Healthtech IPO listing price is ₹116, indicating a potential listing gain of approximately 20.83% over the issue price.
Who is the Influx Healthtech IPO Lead Manager?
The book-running lead managers (BRLMs) for the Influx Healthtech IPO are Rarever Financial Advisors Pvt. Ltd. Pvt. Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Influx Healthtech IPO Red Herring Prospectus (RHP).